FindTrial
Sign In

Construction and validation of a risk prediction model for venous thrombosis in breast cancer patients during intensive therapy

Construction and validation of a risk prediction model for venous thrombosis in breast cancer patients during intensive therapy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100049374
Enrollment
Unknown
Registered
2021-08-01
Start date
2021-09-01
Completion date
Unknown
Last updated
2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

venous thromboembolism

Interventions

Thrombus group:None
No thrombus group:None

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Female patients confirmed by pathological diagnosis as breast malignant tumor; 2.Inpatients who undergo surgery for breast cancer; 3.Life expectancy > 6 months.

Exclusion criteria

Exclusion criteria: 1.Patients aged < 18 years old; 2.Patients with contraindications to color ultrasound detection.

Design outcomes

Primary

MeasureTime frame
Venous thrombosis of the lower and upper extremities;Physical examination;Central duct-associated venous thrombosis;—

Countries

China

Contacts

Public ContactZhang Xiaoxia

West China Hospital, Sichuan University

zhangxiaoxia@scu.edu.cn+86 18980606963

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026